584900092	584900092	CD	B-NP	O
|	|	NN	I-NP	O
ZMC	ZMC	NN	I-NP	O
|	|	NN	I-NP	O
11297206	11297206	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
213875	213875	CD	B-NP	O
|	|	CC	I-NP	O
9/14/1999	9/14/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/14/1999	9/14/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/1999	5/10/1999	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ATRIAL	ATRIAL	NN	B-NP	O
FLUTTER	FLUTTER	NN	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

NON-INSULIN	NON-INSULIN	NNP	B-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

HYPOTHYROIDISM	HYPOTHYROIDISM	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ISCHEMIC	ISCHEMIC	NN	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
CARDIOVERSION	CARDIOVERSION	NNP	I-NP	O
TO	TO	NNP	I-NP	O
SINUS	SINUS	NNP	I-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Zack	Zack	NNP	I-NP	O
Nieman	Nieman	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
62-year-old	62-year-old	JJ	I-NP	O
white	white	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1985	1985	CD	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
posterior	posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
obtuse	obtuse	VB	I-VP	O
marginal	marginal	JJ	B-NP	O
branch	branch	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
first	first	RB	B-NP	O
diagonal	diagonal	JJ	I-NP	O
,	,	,	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
obtuse	obtuse	VB	I-VP	O
marginal	marginal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
posterior	posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
requiring	require	VBG	B-VP	O
AICD	AICD	NN	B-NP	O
placement	placement	NN	I-NP	O
and	and	CC	O	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
hyperthyroidism	hyperthyroidism	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
PTU	PTU	NN	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Levothyroxine	Levothyroxine	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

About	About	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Rorea	Rorea	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
IV	IV	CD	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Echocardiography	Echocardiography	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
LV	LV	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
20	20	CD	I-NP	O
's	's	POS	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
provided	provide	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Scot	Scot	NNP	I-NP	O
Free	Free	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
recent	recent	JJ	B-NP	O
gain	gain	NN	I-NP	O
in	in	IN	B-PP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
recent	recent	JJ	I-NP	O
TSH	TSH	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
10	10	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
excess	excess	JJ	I-NP	O
caffeine	caffeine	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
consumption	consumption	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
hypertension	hypertension	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
non-insulin	non-insulin	JJ	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
morphine	morphine	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
tetanus	tetanus	NN	B-NP	O
toxoid	toxoid	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
66	66	CD	I-NP	O
.	.	.	O	O

Mother	Mother	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
63	63	CD	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Very	Very	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
athletically	athletically	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
works	work	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
superintendant	superintendant	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
appearance	appearance	NN	I-NP	O
,	,	,	O	O
very	very	RB	B-NP	O
pleasant	pleasant	JJ	I-NP	O
man	man	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	B-protein
97.1	97.1	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
148/94	148/94	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
pupils	pupil	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Sclerae	Sclerae	NNP	B-NP	O
anicteric	anicteric	JJ	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
pharynx	pharynx	NN	I-NP	O
clear	clear	JJ	I-NP	O
and	and	CC	I-NP	O
moist	moist	NN	I-NP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
about	about	RB	B-NP	O
8-9	8-9	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	RBS	B-ADJP	O
clear	clear	JJ	I-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
percussion	percussion	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rales	rale	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
paradoxical	paradoxical	JJ	I-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
pulsatile	pulsatile	JJ	I-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
clubbing	clubbing	NN	B-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
19	19	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
220	220	CD	I-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
22	22	CD	I-NP	I-DNA
,	,	,	O	O
ALK	ALK	NN	B-NP	B-DNA
53	53	CD	I-NP	I-DNA
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.8	9.8	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
7.1	7.1	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.4	4.4	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
477	477	CD	I-NP	I-cell_line
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
2.7	2.7	CD	I-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
12.7	12.7	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
24.2	24.2	CD	I-NP	I-protein
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
+	+	SYM	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
block	block	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
versus	versus	IN	I-NP	O
3	3	CD	I-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
rate	rate	NN	B-NP	O
around	around	IN	B-PP	O
120	120	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
bundle	bundle	NN	B-NP	O
branche	branche	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
about	about	IN	B-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
Nes	Nes	NNP	B-NP	B-protein
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-PP	O
A	A	NN	B-NP	O
Hospital	Hospital	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
various	various	JJ	B-NP	O
blocks	block	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
between	between	IN	B-PP	O
120-130	120-130	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
echocardiogram	echocardiogram	NN	B-NP	O
repeated	repeat	VBN	B-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
rapid	rapid	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
loading	loading	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
0.25	0.25	CD	B-NP	O
mg	mg	NN	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	I-NP	O
q.	q.	HYPH	I-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
at	at	IN	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Digoxin	Digoxin	NN	I-NP	O
level	level	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
around	around	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
old	old	JJ	B-NP	O
grafts	graft	NNS	I-NP	O
serving	serve	VBG	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descending	NN	I-NP	O
,	,	,	O	O
posterior	posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
obtuse	obtuse	NN	B-NP	O
marginal	marginal	JJ	I-NP	O
,	,	,	I-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
first	first	JJ	B-NP	O
diagonal	diagonal	NN	I-NP	O
has	have	VBZ	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
estimated	estimate	VBN	B-VP	O
at	at	IN	B-PP	O
10-15	10-15	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Post	Post	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	O
done	done	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardioversion	cardioversion	NN	B-NP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
AICD	AICD	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Electrophysiological	Electrophysiological	NNP	I-NP	O
Service	Service	NNP	I-NP	O
with	with	IN	B-PP	O
successful	successful	JJ	B-NP	O
conversion	conversion	NN	I-NP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
meanwhile	meanwhile	RB	B-ADVP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
until	until	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
between	between	IN	B-PP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
further	far	JJR	B-NP	O
investigation	investigation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
hemochromatosis	hemochromatosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cardiomyopathy	Cardiomyopathy	NN	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
approaches	approach	VBZ	B-VP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Amiodarone	Amiodarone	NN	B-NP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Klonopin	Klonopin	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
a.m.	a.m.	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
sodium	sodium	NN	I-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
420	420	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
mg	mg	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
five	five	CD	B-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
until	until	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
between	between	IN	B-PP	O
2-3	2-3	CD	B-NP	O
then	then	RB	I-NP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
accordingly	accordingly	RB	B-ADVP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
between	between	IN	B-PP	O
2-3	2-3	NN	B-NP	O
,	,	,	O	O
Simvastatin	Simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
,	,	,	O	O
mononitrate-SR	mononitrate-SR	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
troglipazone	troglipazone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NNP	B-NP	O
UPON	UPON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Stable	Stable	NNP	B-NP	O
.	.	.	O	O

DISPOSITION/FOLLOW-UP	DISPOSITION/FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Furbeck	Furbeck	NNP	I-NP	O
,	,	,	O	O
Rudy	Rudy	NNP	B-NP	O
Lonny	Lonny	NNP	I-NP	O
Napoleon	Napoleon	NNP	I-NP	O
D.	D.	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cardiomyopathy	Cardiomyopathy	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
WROBLISKI	WROBLISKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TYSON	TYSON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
ACCOMANDO	ACCOMANDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QG4	QG4	NNP	I-NP	O
NB470/9251	NB470/9251	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
81927	81927	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

YHIR67629F	YHIR67629F	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/10/99	11/10/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/3/99	1/3/99	CD	B-NP	O

